Laporan Laba Rugi (TTM)
Laporan Laba Rugi Envoy Medical, Inc. - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2021 12-31 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -23.55 | -9.70 | 1.87 | 10.55 | 31.12 | -6.01 | 1.68 | -7.95 | -19.06 | -5.78 | 4.72 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -35.24 | -7.63 | -12.17 | 74.75 | 11.76 | -2.79 | 10.82 | -3.65 | -9.40 | 9.84 | -1.35 | |
| % of Revenue | 248.06 | 210.13 | 214.95 | 185.32 | 292.95 | 249.68 | 258.25 | 281.46 | 294.60 | 329.78 | 384.43 | 362.16 |
| Gross Operating Profit | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1 | -1 | -1 | -1 | -1 |
| Change (%) | -43.14 | -5.75 | -24.39 | 150.00 | 1.72 | -0.63 | 16.60 | -1.28 | -4.44 | 16.63 | -3.48 | |
| % of Revenue | -148.06 | -110.13 | -114.95 | -85.32 | -192.95 | -149.68 | -158.25 | -181.46 | -194.60 | -229.78 | -284.43 | -262.16 |
| SG&A | 2 | 3 | 5 | 6 | 7 | 9 | 10 | 9 | 10 | 9 | 8 | 9 |
| Change (%) | 40.32 | 31.56 | 34.04 | 10.03 | 32.63 | 7.65 | -1.51 | 6.97 | -15.48 | -2.93 | 4.16 | |
| % of Revenue | 797.74 | 1,464.14 | 2,133.18 | 2,806.88 | 2,793.78 | 2,825.95 | 3,236.70 | 3,135.10 | 3,643.17 | 3,804.44 | 3,919.34 | 3,898.65 |
| R&D | 4 | 5 | 6 | 7 | 7 | 9 | 9 | 10 | 11 | 10 | 11 | 10 |
| Change (%) | 26.30 | 17.71 | 13.52 | 10.47 | 21.95 | 4.83 | 4.67 | 9.52 | -5.43 | 3.81 | -1.00 | |
| % of Revenue | 1,270.65 | 2,099.16 | 2,736.45 | 3,049.54 | 3,047.30 | 2,834.18 | 3,161.28 | 3,253.97 | 3,871.58 | 4,524.00 | 4,984.43 | 4,712.16 |
| OpEx | 7 | 9 | 11 | 13 | 15 | 19 | 20 | 20 | 22 | 19 | 20 | 20 |
| Change (%) | 24.54 | 21.67 | 21.05 | 12.24 | 26.33 | 5.86 | 1.90 | 7.77 | -10.27 | 1.08 | 1.16 | |
| % of Revenue | 2,316.45 | 3,773.42 | 5,084.58 | 6,041.74 | 6,134.02 | 5,909.81 | 6,656.23 | 6,670.53 | 7,809.35 | 8,658.22 | 9,288.21 | 8,972.97 |
| Operating Income | -7 | -9 | -11 | -13 | -15 | -18 | -19 | -20 | -21 | -19 | -19 | -20 |
| Change (%) | 26.71 | 22.52 | 21.43 | 12.27 | 26.25 | 6.06 | 1.91 | 8.01 | -10.15 | 1.16 | 1.12 | |
| % of Revenue | -2,216.45 | -3,673.42 | -4,984.58 | -5,941.74 | -6,034.02 | -5,809.81 | -6,556.23 | -6,570.53 | -7,709.35 | -8,558.22 | -9,188.21 | -8,872.97 |
| Interest Expense | -0 | -0 | -0 | -1 | -1 | -2 | ||||||
| Change (%) | 366.67 | 157.14 | 88.89 | 56.25 | 38.59 | |||||||
| % of Revenue | -12.12 | -55.63 | -155.40 | -362.67 | -601.42 | -795.95 | ||||||
| Net Income | -9 | -16 | -27 | -39 | -37 | -30 | -23 | -14 | -21 | -21 | -20 | -21 |
| Change (%) | 83.55 | 71.48 | 43.98 | -7.15 | -18.03 | -23.34 | -40.54 | 54.49 | -1.31 | -6.12 | 8.93 | |
| % of Revenue | -2,798.39 | -6,718.57 | -12,759.35 | -18,034.40 | -15,146.89 | -9,468.99 | -7,723.57 | -4,516.56 | -7,579.86 | -9,242.22 | -9,208.96 | -9,579.28 |
Source: Capital IQ
